slides · global inventory
Chart Selection Guide
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 8,343
Current window 5,671-5,700
Pages 279
Rows per page 30
Tool
5,671-5,700 of 8,343
22
The chart compares High vs Low Fidelity models with and without pretraining across different training data sizes.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
25
The slide uses box plots and bar charts to show statistical correlation between naturalness and clinical/developability outcomes.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
26
The slide uses box plots and density plots to demonstrate that higher naturalness correlates with better expression and lower mutational burden.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
The slide uses a line chart to demonstrate performance stability relative to a benchmark.AlTi | Investor Presentation Deck | 46 slides · Alvarium Tiedemann
Pitch deck Investor relations Beat · Solution1 hit
07
The chart includes a callout for growth metrics and a footnote explaining F/X adjustment methodology.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
09
The chart highlights a significant year-over-year decline in operating income.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
11
Includes a footnote regarding a $1.1B pre-tax valuation gain in Q3 2022.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · FinancialsLoop · Logic Chain1 hit
21
The slide uses a visual of a store interior on the left and a growth projection chart on the right.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
22
The slide uses a bar chart to show revenue growth and a callout to highlight the absolute dollar increase and CAGR.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
24
The slide uses a visual callout to emphasize the CAGR and shows the percentage of total net revenue for each period.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
25
The slide uses a bar chart to show historical and projected revenue growth, with a callout highlighting the CAGR.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
26
The slide uses a map graphic as a background element to reinforce the 'International' theme.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
19
The chart uses a bar-vertical format to show relative pricing, with LumiraDx POC positioned as significantly cheaper than other POC solutions.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
25
The slide uses two line charts to compare positivity rates across different test methods (LumiraDx, PCR, Other POC) over time, segmented by COVID-19 variants.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
06
Includes annotations for specific dates and events impacting stock price.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Benchmark Gap1 hit
13
Includes a specific callout for 'Orange' at 8.8x multiple.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Evidence & ProofLoop · Hypothesis Test1 hit
14
Transaction data as of September 2022; excludes withdrawn deals and those by strategic acquirers.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Evidence & ProofLoop · Hypothesis Test1 hit
23
The slide combines a financial table (capitalization) with a time-series chart (price/volume) and event annotations.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
25
Includes a summary table of average multiples across different economic periods.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
28
The slide presents a standard WACC build-up model with sensitivity adjustments.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
26
Uses historical data charts to establish a precedent for government policy driving market adoption.Proterra | Investor Presentation Deck | 28 slides · Proterra
Pitch deck Investor relations 1 hit
07
The slide uses a multi-layered timeline approach to correlate strategic milestones with revenue growth.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations 1 hit
09
The chart shows mean percent change from baseline with standard deviation bars.Roivant Sciences | Investor Presentation Deck | 21 slides · Immunovant
Pitch deck Investor relations 1 hit
31
The chart is a swimmer plot showing patient response over time, including redosing events and disease progression.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations 1 hit
06
The data highlights the mechanism of action of KIT inhibition (inactivation and depletion) supported by Phase 1b interim results.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
11
The chart tracks neutrophil levels across multiple cohorts (placebo, 200mg QD, 200mg Q12H, 400mg Q12H, 500mg QD FED) from Day 1 to Day 70/EOS, with a vertical line marking the end of treatment at Day 14.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
15
The chart shows a pharmacokinetic (PK) profile comparing two formulations of THB001.Third Harmonic Bio | IPO Presentation Deck | 24 slides · Third Harmonic Bio
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
05
The slide uses a before-after comparison for five business metrics, highlighting performance changes in a difficult macro environment.UBS | Results Presentation Deck | 27 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Before After1 hit
21
The chart uses a grouped bar structure to compare two categories (VMC States vs Other States) across four time periods.Vulcan Materials | Investor Day Presentation Deck | 91 slides · Vulcan Materials Company
Conference presentation Investor relations Beat · Evidence1 hit
42
The slide showcases a dashboard-style view of internal commercial analytics.Vulcan Materials | Investor Day Presentation Deck | 91 slides · Vulcan Materials Company
Conference presentation Investor relations Beat · Development1 hit